{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T00:14:57Z","timestamp":1716682497863},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,25]]},"DOI":"10.7759\/cureus.61076","type":"journal-article","created":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T22:00:45Z","timestamp":1716674445000},"source":"Crossref","is-referenced-by-count":0,"title":["Iron Deficiency in Newly Referred Patients With Chronic Renal Failure"],"prefix":"10.7759","author":[{"given":"Mineaki","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoma","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sawase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mukae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.642296","article-title":"Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents","volume":"8","author":"Portol\u00e9s J","year":"2021","unstructured":"Portol\u00e9s J, Mart\u00edn L, Broseta JJ, Cases A. Anemia in chronic kidney disease: from pathophysiology and current treatments, to future agents. Front Med (Lausanne). 2021, 8:642296. 10.3389\/fmed.2021.642296","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.12.011","article-title":"Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD","volume":"69","author":"Gupta N","year":"2017","unstructured":"Gupta N, Wish JB. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD. Am J Kidney Dis. 2017, 69:815-26. 10.1053\/j.ajkd.2016.12.011","journal-title":"Am J Kidney Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.05.009","article-title":"Novel anemia therapies in chronic kidney disease: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"104","author":"Ku E","year":"2023","unstructured":"Ku E, Del Vecchio L, Eckardt KU, et al.. Novel anemia therapies in chronic kidney disease: conclusions from a kidney disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2023, 104:655-80. 10.1016\/j.kint.2023.05.009","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000496492","article-title":"Iron deficiency anemia in chronic kidney disease","volume":"142","author":"Gafter-Gvili A","year":"2019","unstructured":"Gafter-Gvili A, Schechter A, Rozen-Zvi B. Iron deficiency anemia in chronic kidney disease. Acta Haematol. 2019, 142:44-50. 10.1159\/000496492","journal-title":"Acta Haematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000533304","article-title":"Iron supplements concomitant within hypoxia-inducible factor prolyl hydroxylase domain inhibitors in the treatment of chronic kidney disease anemia","volume":"9","author":"Wang X","year":"2023","unstructured":"Wang X, Wei C, Zhao D, et al.. Iron supplements concomitant within hypoxia-inducible factor prolyl hydroxylase domain inhibitors in the treatment of chronic kidney disease anemia. Kidney Dis (Basel). 2023, 9:485-97. 10.1159\/000533304","journal-title":"Kidney Dis (Basel)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-017-0114-y","article-title":"2015 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease","volume":"3","author":"Yamamoto H","year":"2017","unstructured":"Yamamoto H, Nishi S, Tomo T, et al.. 2015 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ren Replace Ther. 2017, 3:1-46. 10.1186\/s41100-017-0114-y","journal-title":"Ren Replace Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfz192","article-title":"Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease","volume":"36","author":"Awan AA","year":"2021","unstructured":"Awan AA, Walther CP, Richardson PA, Shah M, Winkelmayer WC, Navaneethan SD. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021, 36:129-36. 10.1093\/ndt\/gfz192","journal-title":"Nephrol Dial Transplant"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236132","article-title":"Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB)","volume":"15","author":"Sofue T","year":"2020","unstructured":"Sofue T, Nakagawa N, Kanda E, et al.. Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB). PLoS One. 2020, 15:e0236132. 10.1371\/journal.pone.0236132","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.07.032","article-title":"Iron deficiency in CKD without concomitant anemia","volume":"6","author":"Wish JB","year":"2021","unstructured":"Wish JB, Anker SD, Butler J, Cases A, Stack AG, Macdougall IC. Iron deficiency in CKD without concomitant anemia. Kidney Int Rep. 2021, 6:2752-62. 10.1016\/j.ekir.2021.07.032","journal-title":"Kidney Int Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/kisup.2012.37","article-title":"Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease","volume":"2","author":"McMurray JJ","year":"2012","unstructured":"McMurray JJ, Parfrey PS, Adamson JW, et al.. Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl (2011). 2012, 2:279. 10.1038\/kisup.2012.37","journal-title":"Kidney Int Suppl (2011)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gft033","article-title":"Kidney disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement","volume":"28","author":"Locatelli F","year":"2013","unstructured":"Locatelli F, B\u00e1r\u00e1ny P, Covic A, et al.. Kidney disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant. 2013, 28:1346-59. 10.1093\/ndt\/gft033","journal-title":"Nephrol Dial Transplant"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.06.008","article-title":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease: 2007 update of hemoglobin target","volume":"50","year":"2007","unstructured":"KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in chronic kidney disease. 2007 update of hemoglobin target. Am J Kidney Dis. 2007, 50:471-530. 10.1053\/j.ajkd.2007.06.008","journal-title":"Am J Kidney Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2022.09.014","article-title":"Cardiac and kidney adverse effects of HIF prolyl-hydroxylase inhibitors for anemia in patients with CKD not receiving dialysis: a systematic review and meta-analysis","volume":"81","author":"Zheng Q","year":"2023","unstructured":"Zheng Q, Wang Y, Yang H, et al.. Cardiac and kidney adverse effects of HIF prolyl-hydroxylase inhibitors for anemia in patients with CKD not receiving dialysis: a systematic review and meta-analysis. Am J Kidney Dis. 2023, 81:434-445.e1. 10.1053\/j.ajkd.2022.09.014","journal-title":"Am J Kidney Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2258986","article-title":"An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease","volume":"45","author":"Zhao H","year":"2023","unstructured":"Zhao H, Li P, Zhang HL, Jia L. An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease. Ren Fail. 2023, 45:2258986. 10.1080\/0886022X.2023.2258986","journal-title":"Ren Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020091311","article-title":"Phase 3 randomized study comparing vadadustat with darbepoetin alfa for anemia in Japanese patients with nondialysis-dependent CKD","volume":"32","author":"Nangaku M","year":"2021","unstructured":"Nangaku M, Kondo K, Kokado Y, et al.. Phase 3 randomized study comparing vadadustat with darbepoetin alfa for anemia in Japanese patients with nondialysis-dependent CKD. J Am Soc Nephrol. 2021, 32:1779-90. 10.1681\/ASN.2020091311","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand IS","year":"2018","unstructured":"Anand IS, Gupta P. Anemia and iron deficiency in heart failure: current concepts and emerging therapies. Circulation. 2018, 138:80-98. 10.1161\/CIRCULATIONAHA.118.030099","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac569","article-title":"Iron deficiency and cardiovascular disease","volume":"44","author":"Savarese G","year":"2023","unstructured":"Savarese G, von Haehling S, Butler J, Cleland JG, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J. 2023, 44:14-27. 10.1093\/eurheartj\/ehac569","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.84","article-title":"The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences","volume":"16","author":"Klip IT","year":"2014","unstructured":"Klip IT, Jankowska EA, Enjuanes C, et al.. The additive burden of iron deficiency in the cardiorenal-anaemia axis: scope of a problem and its consequences. Eur J Heart Fail. 2014, 16:655-62. 10.1002\/ejhf.84","journal-title":"Eur J Heart Fail"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/252319-iron-deficiency-in-newly-referred-patients-with-chronic-renal-failure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T22:00:49Z","timestamp":1716674449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/252319-iron-deficiency-in-newly-referred-patients-with-chronic-renal-failure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,25]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.61076","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,25]]}}}